Figure 4.
PK parameters for pralatrexate and romidepsin in the study population. (A-B) Concentration over time for each dose cohort of pralatrexate (A) and romidepsin (B). (C) Cmax, Tmax, t1/2, AUC, CI, and Vobs (volume observed) for pralatrexate and romidepsin at each dose cohort.

PK parameters for pralatrexate and romidepsin in the study population. (A-B) Concentration over time for each dose cohort of pralatrexate (A) and romidepsin (B). (C) Cmax, Tmax, t1/2, AUC, CI, and Vobs (volume observed) for pralatrexate and romidepsin at each dose cohort.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal